Personalized skin cancer risk feedback in community health centers
A hybrid effectiveness-implementation trial to integrate precision skin cancer risk feedback in federally qualified health centers
This project gives adults served by community health centers personalized genetic risk information for skin cancer to help them protect their skin and find problems earlier.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | H. Lee Moffitt Cancer Ctr & Res Inst NIH-funded |
| Lab location | 1 site (Tampa, United States) |
| Project ID | NIH-11179295 on NIH RePORTER |
What this research studies
If you join, you would receive information about your inherited risk for skin cancer based on a genetic test (including MC1R) and easy-to-read materials in English or Spanish. The program is being offered through federally qualified community health centers and is designed for people 21 and older. The team will track whether the personalized feedback changes prevention behaviors like sun protection, self-skin checks, and getting clinical skin exams. Staff will also study what makes it easier or harder to use this program in everyday clinic care so it can be used more widely.
Who could benefit from this research
Good fit: Ideal candidates are adults (21+) who receive care at participating federally qualified health centers and want to learn about their genetic risk for skin cancer.
Not a fit: People under 21, those not served by the participating clinics, or individuals already diagnosed with advanced skin cancer are unlikely to benefit from joining this program.
Why it matters
Potential benefit: If successful, this approach could help people adopt better sun-protection and early-detection habits that lower their chances of advanced skin cancer.
How similar studies have performed: Earlier trials using MC1R-based risk feedback by this team showed interest, good follow-through, and improved prevention behavior among higher-risk participants, so this builds on promising prior results.
Where this research is happening
Tampa, United States
- H. Lee Moffitt Cancer Ctr & Res Inst — Tampa, United States (Active)
Researchers
- Principal investigator: Kanetsky, Peter a — H. Lee Moffitt Cancer Ctr & Res Inst
- Study coordinator: Kanetsky, Peter a
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.